Jiawei Cao

458 citations
20 papers · 267 indexed · h-index 11
Topics
Glycosylation and Glycoproteins Research (4 papers)Ferroptosis and cancer prognosis (4 papers)RNA modifications and cancer (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Jiawei Cao

20 papers receiving 266 citations

Peers

Jiawei Cao
Comparison fields: 5 of 61
  • Molecular Biology 157
  • Oncology 88
  • Cancer Research 81
  • Pulmonary and Respiratory Medicine 71
  • Radiology, Nuclear Medicine and Imaging 40
Replace Song-Chang Lin with:
Song-Chang Lin United States
Krishna Luitel United States
Sinan Zhu United States
Jacqueline Watson United States
Christina Wu United States
Ninghui Mao United States
H. Carl LeKaye United States
Jordan M. Blum United States
Marion Gilormini France
Chikako Fukukawa Japan
Jiawei Cao relative to Song-Chang Lin United States Song-Chang Lin's profile →
Citations per field
00.5×1.5×2.2×
Song-Chang Lin · 1×
Citations per year

Countries citing papers authored by Jiawei Cao

Since Specialization
Citations

This map shows the geographic impact of Jiawei Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiawei Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiawei Cao more than expected).

Fields of papers citing papers by Jiawei Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiawei Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiawei Cao. The network helps show where Jiawei Cao may publish in the future.

Co-authorship network of co-authors of Jiawei Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiawei Cao. A scholar is included among the top collaborators of Jiawei Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiawei Cao. Jiawei Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 2
3 2
4 2
5 3
6 19
7 2
8 8
9 11
10 12
11 19
12 21
13 25
14 25
15 12
16 50
17 6
18 12
19 4
20 24

About Jiawei Cao

Jiawei Cao is a scholar working on Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 267 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (4 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (81 citations), Oncology (88 citations) and Molecular Biology (157 citations). Jiawei Cao has collaborated with scholars based in China and United States. Frequent co-authors include Haihua Gu, Robert L. Wells, M. M. Elkind, Hongzhi Li, Licai He, Guang Wu, Kaiyan Yang, Jennifer K. Richer, Hongwei Gao and Guorong Chen. Their work appears in journals such as Oncogene, Scientific Reports and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026